Cambridge Quarterly of Healthcare Ethics

Cambridge Quarterly of Healthcare Ethics
Title	Cambridge Quarterly of Healthcare Ethics
Discipline	Bioethics
Abbreviation	Cambridge Q. Healthc. Ethics
Editor	[See Editorial Board]
Publisher	Cambridge University Press
History	1992–present
Frequency	Quarterly
Issn	0963-1801

Cambridge Quarterly of Healthcare Ethics is a peer-reviewed academic journal dedicated to ethical analysis of clinical practice, health policy, biomedical research, and professional conduct. The journal publishes original articles, commentaries, case studies, and reviews that engage with contemporary debates involving medical institutions, regulatory frameworks, and global health challenges. Contributors and readers include scholars and practitioners associated with universities, hospitals, research institutes, and professional associations.

History

The journal was established in 1992 during a period of intensified ethical scrutiny following high-profile cases and policy reforms in North America and Europe. Early editorial leadership aligned with scholars connected to Harvard Medical School, Oxford University, University of Cambridge, Johns Hopkins University, and University of Toronto, reflecting ties to hospitals such as Massachusetts General Hospital, Great Ormond Street Hospital, Mayo Clinic, University College Hospital, and Toronto General Hospital. Its emergence paralleled institutional developments including the formation of ethics committees at World Health Organization meetings and the expansion of programs at centers like Kennedy Institute of Ethics, Centre for Biomedical Ethics (NUS), Favored names, and the establishment of clinical ethics consultation services at Guy's and St Thomas' NHS Foundation Trust. The journal has documented responses to landmark events such as the AIDS epidemic, the human genome project, the Tuskegee Syphilis Study aftermath, and debates after the Helsinki Declaration revisions.

Scope and Content

The journal addresses intersecting topics spanning clinical dilemmas encountered at St Bartholomew's Hospital, policy disputes involving National Health Service (England), and regulatory questions seen at agencies like Food and Drug Administration, European Medicines Agency, and Health Canada. Articles engage with bioethical questions arising in settings from neonatal intensive care units at Royal Victoria Hospital to oncology wards at MD Anderson Cancer Center, and in research contexts exemplified by protocols at Imperial College London and Fred Hutchinson Cancer Research Center. It covers case analyses related to end-of-life care influenced by rulings such as Cruzan v. Director, Missouri Department of Health and Airedale NHS Trust v Bland, debates over assisted reproduction in the wake of decisions from European Court of Human Rights, and policy discussions connected to initiatives like Affordable Care Act and Medicare. The journal situates ethical argumentation in relation to global health crises tracked by Centers for Disease Control and Prevention, Médecins Sans Frontières, and responses to pandemics such as COVID-19 pandemic.

Editorial Board and Peer Review

The editorial board has featured scholars affiliated with institutions including Yale School of Medicine, University of Chicago, Columbia University, Stanford University School of Medicine, King's College London, University of Edinburgh, McGill University, Peking University Health Science Center, Karolinska Institutet, and University of Melbourne. Members often hold appointments in faculties connected to hospitals like Royal Prince Alfred Hospital and centers like Wellcome Trust. The peer-review process follows standards comparable to journals overseen by bodies such as Committee on Publication Ethics and professional societies including American Society for Bioethics and Humanities, European Society of Philosophy of Medicine and Health Care, International Association of Bioethics, and World Medical Association. Editorial decisions have involved consultation with experts involved in panels at Institute of Medicine and contributors to reports from Nuffield Council on Bioethics.

Publication Details and Indexing

Published quarterly by Cambridge University Press, the journal is available in print and online formats subscribed to by university libraries such as Bodleian Libraries, Harvard Library, Library of Congress, and the British Library. It is indexed in major abstracting services and bibliographic databases including PubMed, Scopus, Web of Science, JSTOR, and EBSCOhost. Institutional subscribers include medical schools such as University of Pennsylvania Perelman School of Medicine, Duke University School of Medicine, UCSF School of Medicine, and organizations like Royal College of Physicians and American Medical Association. The journal's metadata appear in catalogs managed by entities such as CrossRef and citation services used by researchers at Max Planck Institute for Innovation and Competition and libraries of Princeton University.

Reception and Impact

Scholarly reception emphasizes contributions to debates shared with journals like The Hastings Center Report, Journal of Medical Ethics, Bioethics (journal), American Journal of Bioethics, and Kennedy Institute of Ethics Journal. Influential discussions published in the journal have been cited in policy analyses produced by World Health Organization, reports by national bodies such as National Institutes of Health, and legal opinions from courts including Supreme Court of the United States and European Court of Human Rights. The journal has fostered dialogue among academics linked to think tanks like Brookings Institution and Chatham House, and has informed curricula at institutions such as Georgetown University and UCL. Citation metrics track influence alongside rankings from bibliometric services associated with Clarivate Analytics and evaluations used by funding agencies like Wellcome Trust and National Science Foundation.

Notable Articles and Special Issues

Notable contributions have addressed themes including consent and capacity following controversies like Terri Schiavo case, genetics ethics in the era of CRISPR-Cas9, organ transplantation policy influenced by debates at United Network for Organ Sharing, and comparative analyses of reimbursement models influenced by DRG system reforms. Special issues have focused on subjects involving cross-border research overseen by European Commission, resource allocation discussed in relation to World Bank health programs, and crises such as responses to the Ebola virus epidemic in West Africa. Contributors include prominent ethicists and clinicians associated with Peter Singer-type debates, scholars active in committees at Royal Society, and legal scholars whose work intersects with cases like Roe v. Wade and policies shaped by Affordable Care Act. The journal continues to commission thematic issues that bring together authors from centers such as Princeton University, University of Oxford, Harvard University, Yale University, University of Toronto, University of Melbourne, and Peking University, alongside practitioners from hospitals including Johns Hopkins Hospital and Cleveland Clinic.

Category:Bioethics journals